Pharmaceutical preparation for treating pancreatic cancer and application thereof

Abstract

The invention provides a pharmaceutical preparation for treating pancreatic cancer and application thereof. The pharmaceutical preparation comprises the following ingredients in parts by weight: 8-15 parts of dangshen, 10-20 parts of self-heal, 5-15 parts of fried bighead atractylodes rhizome, 10-20 parts of oldenlandia, 20-30 parts of fiveleaf akebia fruit, 10-20 parts of tuckahoe, 10-20 parts of poria cocos, 10-20 parts of rhizoma pleionis, 15-30 parts of roasted malt, 10-15 parts of herba scutellariae barbatae, 10-20 parts of Chinese yam, 5-15 parts of fructus trichosanthis, 10-20 parts of pericarpium arecae, 20-30 parts of grifola umbellata, 10-20 parts of ginger processed pinellia, 10-20 parts of coix seeds, 20-30 parts of panicled swallowwort roots, 20-30 parts of spatholobus stem and 3-5 parts of ardisia crenata. The traditional Chinese medicine prescription is economical and applicable, is used for treating pancreatic cancer by strengthening the spleen and stomach, removing dampness, regulating the flow of qi, promoting blood circulation and relieving toxicity, and is suitable for patients suffering pancreatic cancer in various ages. The pharmaceutical preparation can be combined with multiple chemotherapy drugs for use, so that the tumor focus is reduced, the lifetime of tumor patients is prolonged, the harm and side effects on the body caused by radiotherapy and chemotherapy can be reduced, and the immunity and anti-tumor capability of the body are increased.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a pharmaceutical preparation for treating pancreatic cancer and its application. Background technique [0002] According to the latest statistics in 2014, the estimated number of new cases of pancreatic cancer in developed countries (the United States) ranks 10th in men and 9th in women, accounting for 4th in the mortality rate of malignant tumors. According to the "2013 China Tumor Registration Annual Report", pancreatic cancer ranks the 8th in the incidence of male malignant tumors in my country, and the 7th in the mortality rate of malignant tumors in the population, showing a rapid upward trend worldwide. Pancreatic cancer has a genetic susceptibility. About 10% of pancreatic cancer patients have a genetic background. Patients with hereditary pancreatitis, Peutz-Jeghers syndrome, familial malignant melanoma and other hereditary tumor diseases have a significant risk of pan...

AI Technical Summary

Problems solved by technology

This kind of classification theory is beneficial to teaching, but it is difficult to make a proper registration in clinical practice, and cannot effectively guide clinical practice.

This is also a common problem of over-emphasizing dialectical treatment and ignoring dialectical treatment in recent decades.

Images